Innovex
INVX

Innovex (INVX) analyst forecast and price target

Recent analyst ratings

FirmActionRatingPrice targetDate
CitigroupMaintainedBuy$36.00 from $35.00Aug 26, 2026
BarclaysMaintainedEqual-Weight$27.00 from $26.00Aug 11, 2026
JefferiesInitiated CoverageBuy$34.00Jun 8, 2026
Piper SandlerMaintainedOverweight$34.00 from $33.00May 18, 2026
BarclaysMaintainedEqual-Weight$26.00 from $24.00May 8, 2026
CitigroupInitiated CoverageBuy$35.00May 7, 2026
BarclaysMaintainedEqual-Weight$24.00 from $20.00Mar 3, 2026
Piper SandlerMaintainedOverweight$27.00 from $20.00Dec 18, 2025
BarclaysUpgradedUnderweight → Equal-Weight$20.00 from $14.00Nov 14, 2025
Piper SandlerInitiated CoverageOverweight$20.00Jul 15, 2025
BarclaysMaintainedUnderweight$13.00 from $16.00May 9, 2025
BarclaysMaintainedUnderweight$16.00 from $15.00Mar 5, 2025
BarclaysMaintainedUnderweight$15.00 from $21.00Nov 26, 2024
BarclaysMaintainedUnderweight$21.00 from $22.00May 14, 2024
BarclaysMaintainedUnderweight$22.00 from $23.00Feb 29, 2024
Evercore ISI GroupMaintainedOutperform$40.00 from $44.00Feb 28, 2024
BarclaysMaintainedUnderweight$23.00 from $26.00Nov 2, 2023
BarclaysMaintainedUnderweight$26.00 from $25.00Aug 3, 2023
BarclaysMaintainedUnderweight$25.00 from $27.00May 12, 2023

Frequently asked questions

  • What is the latest analyst rating on INVX?

    On Aug 26, 2026, Citigroup maintained Innovex at Buy with a price target of $36.00.

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.